Additionally, NADPH oxidase knockout mice were safeguarded from heart failure caused by doxorubicin, and NADPH oxidase inhibitors demonstrated a reduction in the damage of cardiomyocytes when exposed to anthracyclines [35,36]. Here, FMO5 is linked to heart failure.